tiprankstipranks
Trending News
More News >
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4

Compare Vicore Pharma Holding AB (6Y4) vs. Competitors

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Vicore Pharma Holding AB
€0.92
€297.41M
-6.29
37.32%
Hansa Biopharma AB
kr37.26
kr3.76B
-4.19
8.13%
3 Buy
0 Hold
0 Sell
Strong Buy
BioInvent International AB
kr30.30
kr1.95B
-6.02
3.67%
SynAct Pharma AB
kr23.80
kr1.11B
-9.82
50.32%
Xspray Pharma AB
kr31.20
kr1.02B
-4.27
-24.17%
Cantargia AB
kr5.49
€1.36B
10.83
192.96%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:6Y4
Vicore Pharma Holding AB
1.03
0.28
37.14%
SE:HNSA
Hansa Biopharma AB
37.26
3.30
9.72%
SE:BINV
BioInvent International AB
29.65
2.30
8.41%
SE:SYNACT
SynAct Pharma AB
21.45
7.21
50.63%
SE:XSPRAY
Xspray Pharma AB
25.10
-8.79
-25.93%
SE:CANTA
Cantargia AB
5.49
3.68
203.99%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts